News
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
SAO PAULO (Reuters) -Brazilian pharmaceutical company EMS on Friday said that local pharmacies will start selling its injector pens aimed at treating diabetes and obesity from August 4. The pens, made ...
52mon MSN
US plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
The Trump administration is contemplating a pilot program to cover weight-loss drugs under Medicare and Medicaid. The ...
Markets are assessing the reshaped US trade landscape after Trump on Thursday laid out steep new tariffs for dozens of ...
Brazilian pharmaceutical company EMS announced the release of Olire and Lirux injector pens for obesity and type 2 diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback